Introduction
Patients become poisoned with anticonvulsant drugs postulated to result from post-ictal depression which may persist for several days after a seizure. in a variety of ways (Table 1 ).1 The prevalence of self poisoning and suicide amongst epileptics is many Anticonvulsant poisoning in children is a significant problem,4 and not surprisingly, epileptics usually times higher than that of the non-epileptic population.2 There are many possible reasons for this, ingest their own anticonvulsants.3,4 Thus the prevalence of acute, carbamazepine overdosage appears including social stigma, employment and marital difficulties, frequent or poorly controlled seizures, to be rising as its role as a therapeutic agent increases. Of 33 cases reported over a 4-year period frightening or affective auras, drug-induced cognitive changes, and the ready availability of drugs in large to one Poisons Centre, 58% occurred in epileptics. 5 In contrast, the incidence of phenobarbitone quantities. In addition, there is a higher prevalence of psychiatric diagnoses such as psychosis, personalpoisoning has declined greatly in recent years as it has been replaced by newer anticonvulsants.6 ity disorders and endogenous depression in those with epilepsy.2,3 Suicide attempts have also been ides. The use of haemodialysis, peritoneal dialysis, and exchange transfusion has not been studied, but but are not readily available and therefore have no practical role in the management of acute overdose.
Carbamazepine
would not be expected to be effective for pharmacokinetic reasons. Management consists of supportive measures. induced cardiovascular toxicity is rare unless the Phenytoin (diphenylhydantoin) overdose has been given parenterally.64 Bradycardia, Phenytoin is a first-line agent in the control of tonicatrioventricular block, decreased cardiac output, clonic and psychomotor seizures, and the prevention hypotension, idioventricular rhythm, ventricular and treatment of seizures associated with neurotachycardia65 and asystole50 have been seen with surgery. It also finds use as an anti-arrhythmic agent, massive doses, but predominantly in patients with especially in digitalis-and tricyclic-antidepressantantecedent heart disease. Cardiotoxicity is probably induced ventricular arrhythmias, including the torthe cause of the rare deaths from phenytoin overdose. sades de pointes variety.25,48 Phenytoin toxicity also Rarely, hepatocellular damage has been recorded results from its deliberate addition by addicts to after phenytoin overdose. crack cocaine in the USA49 to enhance the 'buzz'.
Hyperglycaemia with ketosis has been reported Phenytoin's main site of action is the motor cortex following acute overdosage in both diabetic and where it stabilizes transmembrane flux of ions non-diabetic patients, and may progress to hyperosand reduces post-tetanic potentiation of synapses. molar non-ketotic coma.66,67 Hypoglycaemia has also been reported68 as has hypernatraemic coma.69 Phenytoin also increases brain concentrations of Phenytoin toxicity is not normally seen with gamma-aminobutyric acid (GABA) which has an plasma concentrations of less than 15 mg/l inhibitory action in the cerebral cortex. 50 (60 mmol/l). The presence of nystagmus usually In overdosage, absorption of phenytoin from the indicates concentrations of at least 20 mg/l gastrointestinal tract may be delayed and continue (80 mmol/l) and ataxia, levels of 30-40 mg/l for as long as 60 h,51 due to slow dissolution of the (120-160 mmol/l).50 Deaths are usually associated tablets, poor solubility of the drug and reduced with plasma concentrations exceeding 90 mg/l gastrointestinal motility. As a consequence, peak (360 mmol/l), although some have been recorded at plasma concentrations may not be attained for as levels of 50-70 mg/l (200-280 mmol/l).70 long as 24 to 48 h. However, there is marked interThere is no specific antidote for phenytoin intoxindividual variation, and the half-life in poisoned ication. Most patients require nothing more than adults has varied from 24 to 230 h. 52 The minimum supportive measures. Gastric lavage and the adminishalf-life after overdose in children was 6.8 h. 53 tration of multiple-dose activated charcoal71 should Nausea and vomiting occur within 1-2 h of ingesbe considered if a patient presents within one hour tion of a large overdose of phenytoin. 54 The most of an overdose of phenytoin, provided the airway significant toxic effects are seen in the nervous can be protected, though the clinical benefit is system,55 particularly the cerebellum. As concentraunproven. Seizures should be treated with diazepam tions of the drug increase, spontaneous horizontal 0.1-0.3 mg/kg intravenously to a maximum of 20 mg nystagmus is observed. It is an early and sine qua in an adult. This may be repeated in 10-20 min, if non sign of phenytoin toxicity.55 Later, vertical nysrequired. Hyperglycaemic, non-ketotic coma should tagmus, dysarthria, increasing drowsiness, marked be managed conventionally. Complete heart block ataxia and coarse resting tremor or involuntary is treated initially with atropine 0.6 mg, then by movements become apparent.55 The pupils usually insertion of a temporary pacing wire, if required. remain normal but ophthalmoplegia,56 transient Multiple-dose oral activated charcoal may abduction paresis57 and slow saccades58 have been increase the clearance of phenytoin in adults72,73 reported. The tendon reflexes may be increased59 or and children,74 but there is as yet insufficient eviddecreased60 and extensor rigidity, opisthotonus and ence of associated clinical benefit. Phenytoin is seizures may be seen with high drug concentrations.
highly protein-bound and it is not surprising therefore Cerebellar signs usually resolve when serum concenthat forced diuresis, peritoneal dialysis, exchange trations cease to be toxic, but this may take 4-5 transfusion and haemodialysis have been of little or days. 61 The risk of permanent sequelae appears no value in the management of acute intoxicasmall, and the long-term cerebellar effects of acute tion.75,76 Charcoal haemoperfusion has been used in phenytoin toxicity are controversial, but if present severe poisoning but has produced variable results only occur after massive prolonged exposure to and is of questionable value.77,78 Similarly, plasmaplasma phenytoin concentrations of above 40 mg/l.62 pheresis removes some phenytoin but not sufficient Less common neurological features include hyperto be of value,79 except perhaps in young children kinesia, ballismus, dystonia, asterixis, orofacial dyskiwith features of cardiotoxicity.80 nesia, transient hemiparesis and choreoathetosis, the last occurring mainly in children with pre-existing neurological deficits.55
Sodium valproate (valproic acid)
Coma and respiratory depression are so unusual with phenytoin intoxication that, if present, an addiValproate is used in the treatment of absence (petit mal) seizures, and is therefore mostly used in chiltional explanation should be sought.63 Phenytoin-dren; it is also used as an adjunct in multiple seizure concentrations. Valproate assays, therefore, are of little value in the management of severely poisoned types. It is thought to act by increasing cerebral and cerebellar GABA, an inhibitor of synaptic transmispatients except to confirm the drug ingested.
In the majority of cases of valproate overdose, sion,81 though its precise mechanism is unknown.
Valproate is rapidly absorbed from the gastrointessupportive management is all that is necessary to ensure complete recovery. The drug is rapidly tinal tract, and peak serum concentrations occur 1-4 h after a single therapeutic dose and the halfabsorbed and methods to prevent further absorption are therefore of limited value. Maintenance of good life is 7-15 h in healthy volunteers.82 It localizes in structures with high activities of GABA degradative (2-3 l/day in an adult) urine output and discontinuation of all anticonvulsive drugs and hepatic enzyme enzymes, and is thus distributed mainly to liver, lungs, spleen, skeletal muscle, kidney and gastrointeinducers is usually sufficient to ensure recovery within 24-72 h. The airway should be maintained, stinal tract. 83 The pharmacokinetic disposition of valproate and its metabolites in the course of an and if respiratory depression is present, the patient may require assisted mechanical ventilation after acute overdose do not greatly differ from the therapeutic state. 84 It is thought that the 2-EN-valproate endotracheal intubation. If the patient is comatose, is convulsing or has lost the gag reflex, gastric lavage metabolite may play a role in neurotoxicity, as it has neurotoxic effects in animals,69 and was found to be may be considered after endotracheal intubation if a substantial overdose has been taken up to one at highest serum concentration at the time of greatest neurological sequelae following overdose but this hour previously. Activated charcoal may adsorb valproate requires further evaluation. Valproate and its metabolites are excreted in urine.
remaining in the gut, but its efficacy has not been evaluated. Naloxone was used in a 19-month-old boy who permanent neurological sequelae following overdose, except for one case of blindness due to optic was unconscious after ingesting 2.25 g of sodium valproate.86 No opiates were found on drug screening nerve atrophy, but in this case cerebral hypoxia was a more likely cause.89 Unlike other anticonvulsant of his urine. A less dramatic effect was produced by naloxone in a 22-year-old man,100 and while Farrar drug toxicity, dysarthria, nystagmus and ataxia are not features of poisoning. Asterixis of hands and feet et al. 99 report reduction in apnoeic episodes, there was no improvement in conscious level. Connacher may occur, however, as may myoclonic movements and seizures.90,91 Hypotension is common, and et al. 95 and Mortensen et al.101 also found naloxone to be of no benefit. In general, the patients who did nausea, vomiting and diarrhoea have all been reported. Occasionally they are hyperactive. 92 Acute not respond to naloxone had taken large overdoses and had higher serum valproate concentrations than toxicity seems to be less severe in patients who are regularly taking valproate. 92 those who responded, and the doses of naloxone administered to unresponsive patients were lower. Hypernatraemia, hypoglycaemia, hypocalcaemia, hypophosphataemia and metabolic acidosis have all
The therapeutic role and dose-response relationship of naloxone in valproate intoxication require further been reported91, 93 and, if present 
Conclusions
A 26-year-old man ingested 1.35 g without developing serious toxicity, but patients with high concenOverdosage with anticonvulsant drugs is a serious trations develop symptoms of neurotoxicity including problem and physicians should be particularly alert sedation, ataxia, diplopia, nausea and vomiting. 106 to its occurrence in the epileptic population. The Hypertonia, nystagmus and widening of the QRS majority of patients develop central nervous system interval on the ECG have also been reported.
or cardiovascular symptoms and signs of toxicity. Gastric lavage is recommended if more than ten Knowledge of overdosage with the newer anticontablets have been ingested by an adult within 1-2 h. vulsant drugs such as lamotrigine and vigabatrin is Activated charcoal should be given, although it is of limited, and clinicians should be encouraged to unproven benefit. The cardiac rhythm should be report any cases encountered in the literature. monitored.
Meticulous supportive care is required to achieve a good outcome in anticonvulsant drug poisoning; gastric lavage and activated charcoal should be given Vigabatrin if the patient presents within 1-2 h of the overdose. Specific elimination methods such as haemodialysis A relatively new anticonvulsant used for the treator haemoperfusion are kinetically unfavourable and ment of complex partial seizures with or without of doubtful clinical efficacy, as they tend to remove secondary generalisation. It is often used as an only a few therapeutic doses of tablets and fail to adjunct when monotherapy has failed. It is an alter the clinical course of poisoning. irreversible enzyme inhibitor of GABA aminotransferase. 107 Oral absorption of therapeutic doses is rapid and almost complete, and plasma concentrations References peak at approximately 2 h after dosing. The elimination half-life is 5-7 h, but its duration of action is 
